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We describe the characterization of an 80-kDa protein cross-reacting with a monoclonal antibody against the human La
autoantigen. The 80-kDa protein is a variant of rabip4 with an N-terminal extension of 108 amino acids and is expressed
in the same cells. For this reason, we named it rabip4. rabip4 is a peripheral membrane protein, which colocalized with
internalized transferrin and EEA1 on early endosomes. Membrane association required the presence of the FYVE domain
and was perturbed by the phosphatidylinositol 3-kinase inhibitor wortmannin. Expression of a dominant negative rabip4
mutant reduced internalization and recycling of transferrin from early endosomes, suggesting that it may be functionally
linked to rab4 and rab5. In agreement with this, we found that rabip4 colocalized with the two GTPases on early
endosomes and bound specifically and simultaneously to the GTP form of both rab4 and rab5. We conclude that rabip4
may coordinate the activities of rab4 and rab5, regulating membrane dynamics in the early endosomal system.
INTRODUCTION
All eukaryotic cells internalize cell surface proteins and
material from their environment by (receptor-mediated) en-
docytosis (Mellman, 1996; Mukherjee et al., 1997). The path-
way is also used for the recycling of proteins of the secretory
pathway (Lewis et al., 2000). Ligands are bound to receptors
at the cell surface. The complex then enters clathrin-coated
pits that pinch off the plasma membrane to form clathrin-
coated vesicles. These rapidly lose their coat and subse-
quently fuse and deliver their cargo to early endosomes
(EEs). The mildly acidic pH in the lumen of EEs causes
dissociation of many ligand–receptor complexes and assists
in sorting cargo molecules to different intracellular compart-
ments. Ligands are often targeted to late endosomes/lyso-
somes for degradation, whereas most receptors are trans-
ported via recycling endosomes back to the cell surface for
reutilization. Although the pathways of endocytosis are rel-
atively well understood at the descriptive level, our knowl-
edge of the molecular principles that regulate vesicular
transport through EEs is still in its infancy.
The limiting membrane of EEs is enriched in phosphatidyl-
inositol 3-phosphate [PI(3)P], whereas late endosomes and
multivesicular bodies contain PI(3)P on the membrane of their
internal vesicles (Fernandez-Borja et al., 1999; Gillooly et al.,
2000). PI(3)P binds to peripheral membrane proteins contain-
ing a FYVE domain and may serve as docking site on EEs
(Burd and Emr, 1998; Gaullier et al., 1998; Patki et al., 1998). The
FYVE-finger consists of eight conserved cysteines at defined
distances (C-X2-C-X12-C-X2-C-X4-C-X2-C-X16-C-X2-C) and
folds into a so-called “cross-braced” topology in coordination
with two Zn2 ions (Schwabe and Klug, 1994; Stenmark et al.,
1996). In addition, it contains a R(R/K)HHCRXCG motif en-
compassing the third and fourth cysteine (Stenmark and Aas-
land, 1999). Several FYVE-finger proteins, including EEA1 (Si-
monsen et al., 1998), rabenosyn-5 (Nielsen et al., 2000; de Renzis
et al., 2002), and endofin (Seet and Hong, 2001) have been
shown to be important for the orderly flow of membrane
through EEs in mammalian cells.
Importantly, both EEA1 and rabenosyn-5 are effector mol-
ecules of the small GTPase rab5 that is associated with
coated vesicles and EEs and required for homotypic EE
fusion and heterotypic fusion of coated vesicles with EEs.
rab5 is essential for the binding of EEA1 to EEs, and the
combinatorial association of EEA1 with both PI(3)P and rab5
causes its highly restricted intracellular location to EEs
(Gaullier et al., 1998; Simonsen et al., 1998). Because EEA1
functionally associates with the endosomal SNARE protein
syntaxin 13 in an oligomeric protein complex (McBride et al.,
1999), it is thought that rab5 in its GTP-bound form recruits
cytoplasmic effector proteins and membrane-bound
SNAREs to form a microdomain on EEs involved in tether-
ing and fusion (So¨nnichsen et al., 2000). rabenosyn-5 is also
involved in biosynthetic transport of cathepsin D to lyso-
somes and linked to an unknown soluble N-ethylmaleimide-
sensitive factor attachment protein receptor (SNARE) com-
plex through an interaction with the syntaxin binding
protein hVps45p (Nielsen et al., 2000). Other FYVE-finger
proteins are involved in signal transduction pathways at the
cell surface and EEs. For instance, SARA is required for the
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recruitment of the effector molecules Smad2 and Smad3 to
the activated transforming growth factor- receptor on the
cell surface and EEs (Tsukazaki et al., 1998; Panopoulou et al.,
2002), and the localization of SARA to EEs is essential for
nuclear translocation of Smad2 (Hayes et al., 2002). Smad2
also binds to the FYVE domain protein Hrs (Urbe et al., 2000)
that together with SARA, stimulates activin receptor-medi-
ated signaling (Miura et al., 2000). Because Hrs is a key
component in sorting of ubiquitinated cell surface receptors
in EEs (Raiborg et al., 2001, 2002; Bache et al., 2003), it is clear
that FYVE proteins may serve as critical determinants in
integrating membrane transport and signal transduction.
The La protein is an evolutionarily conserved RNA-bind-
ing phosphoprotein, originally identified as an autoantigen
in patients suffering from the autoimmune diseases
Sjo¨gren’s syndrome and systemic lupus erythematosus
(Pruijn, 1994; Maraia and Intine, 2001). La has been impli-
cated in RNA polymerase III transcription and internal ini-
tiation of translation of certain viral RNAs. Its best docu-
mented activity is the binding to and stabilization of newly
synthesized RNA polymerase III transcripts, and La has
been proposed to act as an RNA chaperone (Maraia and
Intine, 2001). To further explore the function of La, we have
used the monoclonal antibody (mAb) SW5, which recog-
nizes a conformational epitope in the RNP domain of La
(Pruijn et al., 1995). We here describe the characterization of
a protein that cross-reacted with SW5. This protein, previ-
ously termed EEA2 (Fouraux et al., 2002a) and now renamed
rabip4, is a novel FYVE-finger domain protein that is func-
tionally associated with EEs and may serve as a novel effec-
tor of rab5 and rab4.
MATERIALS AND METHODS
Antibodies
The monoclonal antibodies SW5 and SW3 against human La (Pruijn et al.,
1995) and the rabbit antibodies raised against LAMP-1 (Harter and Mell-
man, 1992), GSTrab4 (10503) (Bottger et al., 1996), and a rab4 peptide (8091)
(van der Sluijs et al., 1992a) have been described. The mouse monoclonal
antibodies against the VSV-G and hemagglutinin (HA) epitope tags were
purchased from Roche Diagnostics (Almere, The Netherlands), and against
the FLAG from Sigma Chemie (Dordrecht, The Netherlands). The sheep
antibody against TGN46 was from Serotec (Oxford, United Kingdom), and
the goat antibody against rabaptin5 was from Santa Cruz Biotechnology
(Santa Cruz, CA). The rabbit antibody against EEA1 and mouse mAb 4F11
against rab5 were generously provided by Silvie Urbe (Physiological Lab-
oratory, Liverpool, United Kingdom) and Angela Wandinger-Ness (De-
partment of Pathology, University of New Mexico, Albuquerque NM).
rabip4 antibodies were generated in rabbits by immunization with KLH-
conjugated peptides corresponding to aa 93–107 and 302–316 (SN569,
SN570), or with GSTrabip4 (aa 201– 400) (#289). Horseradish peroxidase-
labeled secondary antibodies were from Dako Immunoglobulins
(Glostrup, Denmark). Fluorescently labeled reagents were from Molecular
Probes (Leiden, The Netherlands).
Cell Culture and Transfection
HEp-2 cells and HeLa cells were maintained in DMEM containing 10%
heat-inactivated fetal calf serum, penicillin, and streptomycin. HeLa cells
were transfected using FuGENE6 (Roche Diagnostics) according to the man-
ufacturer’s protocol. Expression from cytomegalovirus-driven constructs was
induced with 5 mM sodium butyrate, and cells were used for experiments
18–24 h after transfection.
Subcellular Fractionation
S100 extracts were prepared from HeLa cells as described previously
(Fouraux et al., 2002a). HEp-2 cells were washed with ice-cold phosphate-
buffered saline, resuspended in 10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM
MgCl2, and incubated on ice for 10 min. Cells were dounced using a type B
pestle, and nuclei and unbroken cells were removed by centrifugation at
600  g. The postnuclear supernatant was centrifuged at 10,000  g to pellet
mitochondria. Finally, the postmitochondrial supernatant was centrifuged at
100,000  g to generate membrane and cytosol fractions. Pellets were solubi-
lized in the same buffer supplemented with 1% SDS. Mitochondria and
membrane fractions were resuspended in 20% of the volume of the cytosol
and nuclear fractions.
Isolation and Cloning of rabip4
Preparative immunoprecipitations from HeLa and Q-TOF mass spectrometry
were done as described previously (Raymackers et al., 2000; Fouraux et al.,
2002b). Peptide sequences were used to identify expressed sequence tags
(ESTs), which enabled us to assemble a contig comprising 88% of full-length
rabip4. Screening of the human genome database with this contig led to the
identification of a sequence that potentially corresponded to the N-terminal
part of rabip4. This sequence was corroborated by the database deposition of
an expressed sequence tag (accession no. BE745186) that was identical to the
sequence derived from the genomic library. The complete N-terminal part (aa
1–87) was cloned from genomic HeLa cell DNA by polymerase chain reaction
(PCR) by using the Advantage-GC cDNA kit (BD Biosciences Clontech,
Leusden, The Netherlands). The remaining part of the coding sequence (aa
87–708) was isolated by PCR from a human placental cDNA library and fused
to the N-terminal part encoding aa 1–87 to generate a full-length rabip4
cDNA (GenBank accession no. AF312367).
Expression Constructs
Constructs encoding N-terminally or C-terminally VSV-G–tagged rabip4
and truncation mutants, N-RUN (aa 1–290), N-RUN-CC1 (aa 1–378), N-
RUN-CC12 (aa 1–514), LZ1-CC1 (aa 205–378), LZ1-CC12 (aa 205–514),
LZ1-CC13 (205– 636), LZ1-CC13-FYVE (205–708), N-RUN-CC13 (aa 1– 636),
and CC13-FYVE (aa 291–708) rabip4 were described previously (Fouraux
et al., 2002a). CC13-FYVE was also ligated into pGEX for recombinant
protein production. rab4, rab5, and rab11 plasmids were described previ-
ously (Roberts et al., 2001; Deneka et al., 2003). rab7-pRP269 was gener-
ously provided by Jacques Neefjes (Dutch Cancer Institute, Amsterdam,
The Netherlands), and rab21pGEX and rab22b-pGEX by Jack Fransen
(Department of Cell Biology, Nijmegen University, Nijmegen, The Neth-
erlands). cDNAs encoding rab15, rab17, and rab27 were provided by Lisa
Elferink (Department of Biological Sciences, Wayne State University, De-
troit, MI), Walter Hunziker (Institute of Biochemistry, University of Lau-
sanne, Lausanne, Switzerland), and Bill Gahl (National Institutes of
Health, Bethesda, MD), respectively, and were cloned in pGEX plasmids.
FLAG-tagged RUFY1-pCMV and a plasmid containing the isolated FYVE
domain of RUFY1 domain with an HA epitope tag, HA-RUFY1-FYVE-
pCMV, were from Yun Qiu (Department of Pharmacology, University of
Minnesota, Minneapolis, MN). Because the FYVE domain of RUFY1 is
identical to that of rabip4, we named this construct HA-rabip4-FYVE-
pCMV. The FENS-1-FYVE-pEGFP construct was provided by Phil
Hawkins (Inositide Laboratory, The Babraham Institute, Cambridge,
United Kingdom).
Binding Assays with 35S-Labeled rabip4 Constructs
GSTrab fusion proteins were expressed in Escherichia coli BL21(DE3), immo-
bilized on glutathione (GSH)-Sepharose beads and charged with guanosine
5-O-(3-thio)triphosphate (GTPS) or GDP as described previously (Christo-
foridis et al., 1999). 35S-Labeled rabip4 constructs were produced by in vitro
transcription-translation and incubated overnight at 4°C with the beads.
Beads were washed three times at 4°C with 50 mM HEPES, pH 8.0, 150 mM
NaCl, 5 mM -mercaptoethanol, 0.05% Tween 20, 1 mM GTPS or GDP
(Nielsen et al., 2000). Bound material was eluted with 25 mM reduced gluta-
thione, resolved by SDS-PAGE on 10% SDS-PAA gels, and analyzed by
phosphorimaging on a STORM 860. For mapping the binding domains on
rabip4, equal amounts of radiolabeled in vitro translated rabip4 truncation
mutants were used as input.
Binding Assays with Ternary Complexes
GST, GSTrabip4 (CC13-FYVE), GSTrab4, and GSTrab5 were expressed in E.
coli BL21 and immobilized on GSH-Sepharose beads. GSTrab4 and GSTrab5
were loaded with GTPS as described previously (Christoforidis et al., 1999).
Fusion proteins were cleaved with thrombin (Sigma, Dordrecht, The Nether-
lands) for 2 h at room temperature, unless indicated otherwise. Thrombin was
then inactivated by 1 mM benzamidine, and released proteins were incubated
twice with 250 l of GSH beads for 1 h at 4°C to remove GST and noncleaved
fusion protein. Twenty microliters of beads containing 200 g of GSTrab5-
GTPS or GST were incubated for 2 h at 4°C with 100 g of rabip4 in buffer
A containing 20 mM HEPES, pH 7.5, 100 mM NaCl, 5 mM MgCl2, 1 mM
dithiothreitol (DTT), and 10 M GTPS in presence of 10 mg/ml bovine
serum albumin (BSA). After washes with buffer A, beads were further incu-
bated for 2 h at 4°C with 500 g of rab4-GTPS in buffer A containing 10
mg/ml BSA. Eluted proteins were separated by SDS-PAGE and analyzed by
Western blotting. For competition experiments, 20 l of beads containing 50
g of GSTrabip4 or GST was incubated for 2 h at 4°C with constant amounts
of rab5-GTPS in buffer A containing 10 mg/ml BSA, washed as described
above, and incubated for another 2 h at 4°C with increasing amounts of
rab4-GTPS in buffer A supplemented with 10 mg/ml BSA. Beads were
washed twice with 500 l of buffer A; once with 500 l of buffer B containing
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20 mM HEPES, 250 mM NaCl, 5 mM MgCl2, 1 mM DTT, and 10 M GTPS,
pH 7.5; and once with 500 l of buffer C containing 20 mM HEPES, 250 mM
NaCl, and 1 mM DTT, pH 7.5. Bound proteins were eluted with buffer D
containing 20 mM HEPES, 1.5 M NaCl, 20 mM EDTA, 1 mM DTT, and 5 mM
GDP, pH 7.5. Eluted proteins were separated by SDS-PAGE and analyzed by
Western blotting.
Internalization and Recycling of Alexa-labeled Transferrin
(Tf)
HeLa cells grown on 10 mm round coverslips were incubated for 30 min in
serum-free DMEM. For steady-state internalization experiments, cells were
washed once with uptake medium (DMEM, 20 mM HEPES, pH 7.4, 0.5%
Figure 1. (A) Sequence and domain structure of rabip4. Deduced amino acid sequence of rabip4. Peptide sequences obtained by mass
spectrometry are depicted in italics above the amino acid sequence. Leucine zipper motifs are underlined, the RUN motif is in italics,
predicted coiled-coil domains are in bold, and the FYVE-finger domain is in bold italics. (B) Schematic structure of rabip4. Coiled-coil
domains are indicated with CC1, CC2, and CC3, the FYVE-finger domain with FYVE, leucine zippers with LZ1 and LZ2, and the RUN motif
by RUN. (C) A Western blot of lysate from nontransfected HeLa cells (NT) was probed with an antibody against rabip4(aa201–400) that
detects 2 bands at 69 kDa and 80 kDa that were not seen by the preimmune (pi) serum. As positive controls, we used lysates of HeLa cells
that were transfected with either VSV-G-rabip4 or FLAG-RUFY1 and detected with epitope tag antibodies.
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Figure 2. (A) The FYVE domain is re-
quired for membrane binding of rabip4.
HEp-2 cell lysates were fractionated as de-
scribed in MATERIALS AND METHODS.
Cytosolic (Cy), nuclear (Nu), mitochondrial
(Mi), and microsomal (Me) fractions were
analyzed by Western blotting by using a
rabbit antibody against rabip4. HeLa cells
were transfected with VSV-G-tagged
rabip4 (B–D) or N-RUN-CC13 mutant
(rabip4FYVE) lacking the FYVE domain
(B and E). Cell lysates were resolved by
SDS-PAGE and analyzed by Western blot-
ting with an antibody against the epitope
tag. Both constructs are expressed at the
same level (B). HeLa cells expressing VSV-
G–tagged rabip4 (C) were incubated for 15
min at 37°C with 50 nM wortmannin (D).
Cells were fixed 18–24 h after transfection,
doubly labeled with mouse anti VSV-G and
rabbit anti-EEA1, stained with Alexa488-la-
beled rabbit anti-mouse and Cy3-labeled
goat anti-rabbit, and examined by fluores-
cence microscopy. Note extensive colocal-
ization between rabip4 and EEA1 in C. In
wortmannin-treated cells, rabip4 redistrib-
uted partially in the cytoplasm but also co-
localized with EEA1 on enlarged endo-
somes (arrows in D). Double-label
immunofluorescence of cells transfected
with VSV-G-tagged N-RUN-CC13 and en-
dogenous EEA1 shows that the construct
lacking the FYVE domain is localized in the
cytoplasm (E). Bar, 10 m.
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BSA) and incubated for 30 min with 25 g/ml Alexa594-Tf at 37°C. The cells
were next fixed with 3% paraformaldehyde for 15 min at 37°C, followed by 30
min of 3% paraformaldehyde at room temperature. For pulse chase experi-
ments, cells were washed with uptake medium and incubated with 25 g/ml
Alexa594-Tf for 30 min at 16°C. After one wash with DMEM, 20 mM HEPES,
pH 7.4, 0.5% BSA, the cells were reincubated at 37°C with prewarmed
medium (DMEM, 20 mM HEPES, pH 7.4, 0.5% BSA, 50 M Desferal) for
different periods of time and then fixed with 2.5% paraformaldehyde. Fixed
cells were subsequently subjected to immunofluorescence microscopy as
described below.
Miscellaneous Methods
SDS-PAGE, Western blotting, and confocal immunofluorescence microscopy
was done as described previously (Sprong et al., 2001). The predicted protein
sequence of rabip4 was analyzed using COILS and SMART software (Lupas,
1996; Schultz et al., 1998). Gel filtration of a HeLa S100 extract was done on a
Superdex 200 HR 10/30 column (Pharmacia, Roosendaal, The Netherlands),
calibrated with thyroglobulin (670 kDa), bovine gammaglobulin (158 kDa),
and chicken ovalbumin (44 kDa). Chromatography was performed at a flow
rate of 0.5 ml/min in 25 mM Tris-HCl, pH 7.5, 50 mM KCl, 1 mM dithio-
Figure 3. rabip4 is associated with early endosomes. HeLa cells were transiently transfected with VSV-G–tagged rabip4. To label the TfR
pathway, cells were incubated for 30 min at 37°C with 25 g/ml Alexa594-Tf (A–C). The cells were fixed and subjected to confocal
immunofluorescence microscopy. rabip4 was labeled with a mAb against the VSV-G tag and counterstained with Alexa488-labeled goat
anti-mouse IgG (A and C) or Cy3-labeled goat anti-mouse IgG (D, F, G, and I). TGN46 detection was with a sheep antibody and Alexa488-goat
anti-sheep (E and F), whereas LAMP-1 was detected with a rabbit antibody against its cytoplasmic tail and stained with Alexa488-goat
anti-rabbit IgG (H and I). Merged images are shown in C, F, and I. Bar, 10 m.
rabip4, a Novel Early Endosomal Protein
Vol. 15, February 2004 615
erythritol, 1 mM phenylmethylsulfonyl fluoride, and fractions were analyzed
by Western blotting. Fusion proteins were expressed at 30°C in E. coli
BL21(DE3) and retrieved on GSH beads. In vitro transcription translation
reactions were done in the presence of [35S]methionine by using the TNT T7
Quick Coupled Reticulocyte Lysate system (Promega, Leiden, The Nether-
lands) as described previously (Bottger et al., 1996).
RESULTS
Identification and Cloning of rabip4
To identify proteins interacting with La, we immunoprecipi-
tated La from HeLa S100 extracts with the SW5 antibody.
One of the coprecipitated proteins had an apparent molec-
ular weight of 80 kDa (Fouraux et al., 2002a). We renamed
this protein rabip4 for reasons documented below. To iden-
tify the protein, we excised the 80-kDa band, incubated it
with trypsin, and subjected the digest to tandem Q-TOF
mass spectrometry. As shown in Figure 1A, this yielded
several peptide sequences, none of which, however, allowed
us to identify the protein.
BLAST searches yielded six human ESTs (accession nos.
AI652188, AW978202, BE000558, AA324714, AW957168, and
AA608559), each encoding a number of the peptides. Based
on those, we assembled a contig comprising sequences en-
coding the identified peptides. A poly-A signal (AATAAA)
was found near the 3 end, but the 5 end was not complete
because the sequence encoding peptide AGLGGGDS (Figure
1A) was present in the contig upstream of the first in-frame
methionine codon. Moreover, all ESTs of this region started
with a NotI site, and NotI digestion had been performed to
generate the clones encoding these ESTs. We screened the
human genome database with this contig and obtained the
complete 5 end of the rabip4 coding sequence (accession
no. AC023559). This sequence has a high GC content (78%)
in the 5 region that may have precluded its synthesis by 5
rapid amplification of cDNA ends analysis (our unpublished
data). Based on these sequence data, we generated a full-
length clone from a human placenta cDNA library and a
genomic fragment isolated by PCR from HeLa cell DNA.
The integrity of the 5 region of the rabip4 coding sequence
was confirmed by a recent EST database entry (accession no.
BE745186) comprising nucleotides 17–700. The full-length
2.63-kb rabip4 clone contains an open reading frame of 2124
nucleotides, which encodes a polypeptide of 708 amino ac-
ids with a calculated molecular mass of 79.8 kDa (Figure 1A;
Figure 4. rabip4 regulates Tf transport through early endosomes. HeLa cells were transfected with VSV-G–tagged rabip4 (A–D) or the
VSV-G–tagged CC13-FYVE rabip4 mutant (E–H). Cells were labeled with mouse anti-VSV-G tag followed by Alexa488-goat anti-mouse IgG
(A–H). Alexa594-Tf was taken up for 30 min at 16°C, washed, and chased at 37°C for 0 min (A and E), 10 min (B and F), 20 min (C and
G), and 40 min (D and H) in the presence of 50 mM Desferal. The corresponding merged images are shown in A–H. Bar, 10 m.
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GenBank accession no. AF312367). The 80-kDa protein is
highly homologous to two recently identified proteins; the
C-terminal 85% is virtually identical to human RUFY1 (Yang
et al., 2002), and the same part shares 94% identity with
mouse rabip4 (Cormont et al., 2001). In comparison with
RUFY1 and rabip4, it contains a unique 108 aa N-terminal
extension. Importantly, this region, which is most likely
encoded by an alternative exon, contains peptide sequence
AGLGGGDS that was identified by mass spectrometry of
the 80-kDa band. For this reason, we named it rabip4.
Sequence analysis predicts that rabip4 is a hydrophilic pro-
tein containing three regions that adopt a mainly -helical
conformation with heptad repeats characteristic of coiled-
coil domains (CC1–CC3) (Lupas, 1996). Leucine zippers are
present at amino acid positions 213–234 and 318–339, the
second of which (LZ2) overlaps with the most N-terminal
coiled-coil domain (CC1). rabip4 contains a RUN domain in
the N-terminal region (aa 139–271), thus encompassing LZ1,
and a FYVE domain close to the C terminus (aa 634–701)
(Figure 1B). The RUN domain is a recently identified protein
sequence of unknown function, which occurs in several
proteins that interact with rab and rap GTPases (Callebaut et
al., 2001). To investigate whether rabip4 and RUFY1 are
both present in human cells, we generated an antibody
(#289) against rabip4(aa201–400), a region that is conserved
between the two proteins. On a Western blot of nontrans-
fected HeLa cells, the antibody detected two bands of the
same intensity at 80 kDa and 69 kDa that correspond to the
size of rabip4 and RUFY1, respectively (Figure 1C). They
also comigrated with individually overexpressed VSV-G–
tagged rabip4 and FLAG-tagged RUFY1, which served as
positive controls. Thus endogenous rabip4 and RUFY1 are
present in HeLa cells at similar levels.
The FYVE Domain Is Essential for Membrane Association
of rabip4
To assess the intracellular localization of rabip4, we first
fractionated HEp-2 cell lysates by differential centrifuga-
tion. The distribution of rabip4 among nuclear, mito-
chondrial, microsomal, and cytosolic fractions was ana-
lyzed by Western blotting by using a peptide antibody
against rabip4 (SN569) (Fouraux et al., 2002a). As shown
in Figure 2A, we found the majority of rabip4 in the
cytosolic fraction, whereas a significant amount was also
present in the microsomal fraction. The nuclear and mi-
tochondrial fractions contained little if any rabip4. Be-
cause rabip4 likely associates with membranes in a re-
versible manner, it may have dissociated in part from
membranes during fractionation as was observed before
for other proteins lacking a membrane anchor (Stenmark
et al., 1995; Simonsen et al., 1998). To further explore
membrane-association of rabip4, we analyzed its distri-
bution by confocal immunofluorescence microscopy. Be-
cause our antibodies did not allow reliable detection of
endogenous rabip4 in morphological assays, we trans-
fected HeLa cells with rabip4 constructs that were N-
terminally tagged with the VSV-G epitope tag (Soldati
and Perriard, 1991). To investigate whether the FYVE
domain of rabip4 is involved in its association with the
cytoplasmic organelles, we transiently expressed the N-
RUN-CC13 rabip4 mutant in which aa 636 –708 were
deleted. Western blots prepared from lysates of the trans-
fectants showed that wild-type and mutant rabip4 were
expressed to the same level (Figure 2B).
As shown in Figure 2C, rabip4 was associated with dis-
crete punctae scattered throughout the cytoplasm, which are
reminiscent of endocytic organelles. The same localization
was found with a construct in which the epitope tag was
fused to the C-terminus (our unpublished data), document-
ing that the tag did not affect the distribution of rabip4. In
cells expressing high levels of rabip4, part of the protein
distributed into the cytoplasm, suggesting that membrane
binding is saturable. Because the cytoplasmic structures con-
taining VSV-G–tagged rabip4 could be endocytic or-
ganelles, we performed double label immunofluorescence
microscopy with EEA1 and found partial colocalization with
Figure 5. rabip4 FYVE domain does not
affect endosome morphology and Tf recy-
cling. Pulse-chase experiments in control
HeLa cells (A and B) or HeLa cells trans-
fected with HA-rabip4-FYVE (C–D) or
GFP-FENS1-FYVE (E–F). Cells expressing
HA-rabip4-FYVE were labeled with mouse
anti-HA tag followed by Alexa488-goat an-
ti-mouse IgG (C and D), whereas expression
of GFP-FENS1-FYVE was visualized by the
GFP signal (E and F). Alexa594-Tf was in-
ternalized for 30 min at 16°C, washed, and
chased at 37°C for 0 min (A, C, and E), and
20 min (B, D, and F) in the presence of 50
mM Desferal. Arrows denote colocalization
of Alexa594-Tf and GFP-FENS1-FYVE.
Bar,10 m.
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this early endosome marker (Figure 2C). Expression of the
rabip4 truncation mutant lacking the FYVE domain re-
vealed a cytoplasmic distribution (Figure 2E) suggesting
that this domain is essential for localization to early endo-
somes. Preextraction of the cells with 0.05% saponin re-
moved all rabip4 from the cells (our unpublished data),
confirming that the FYVE domain is required for binding of
rabip4 to membranes.
Figure 6. rab4 and rab5 bind directly to
rabip4. (A) GST, GSTrab4, GSTrab5, and
GSTrab11 were loaded with GTPS or GDP
and incubated overnight with 35S-labeled
VSV-G–tagged rabip4. Beads were washed
three times, and proteins were eluted with
25 mM reduced glutathione. Eluates were
resolved on 10% SDS-PAA gels and ana-
lyzed by phosphorimaging. (B) GST,
GSTrab4, GSTrab5, GSTrab7, GSTrab15,
GSTrab17, GSTrab21, GSTrab22b, and
GSTrab27 were loaded with GTPS and in-
cubated with 35S-labeled VSV-G–tagged
rabip4 as described in A. rabip4 was
eluted with glutathione and analyzed by
SDS-PAGE and phosphorimaging. (C) Sche-
matic representation of rabip4 truncation
mutants. See legend to Figure 1B for domain
nomenclature. GSTrab4 and GSTrab5 were
loaded with GTPS. Binding and analysis of
35S-labeled VSV-G–tagged rabip4 (fl) and
truncations N-RUN-CC13 (1), LZ1-CC13-
FYVE (2), CC13-FYVE (3), LZ1-CC13 (4), N-
RUN-CC12 (5), N-RUN-CC1 (6), N-RUN
(7), LZ1-CC12 (8), and LZ1-CC1 (9) was
done as described in MATERIALS AND
METHODS.
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FYVE domains bind with moderate affinity to PI(3)P, a
phosphorylated phosphatidylinositol derivative required
for membrane association of EEA1(Lawe et al., 2002). We
therefore next assessed whether PI(3)P might be important
for membrane binding of rabip4. HeLa cells transiently
transfected with full-length rabip4 were incubated for 15
min at 37°C with 50 nM wortmannin. The presence of the
PI3-kinase inhibitor dramatically changed the distribution of
rabip4 from early endosomes to the cytoplasm (Figure 2D).
Some rabip4 remained associated with enlarged vacuolar
structures that also labeled for EEA1, suggesting that an-
other determinant in rabip4 also contributes to its binding
to early endosomes. The same effect of PI3-kinase inhibitors
on EEA1 containing endosomes had been noted previously
(van Dam and Stoorvogel, 2002) in HeLa cells. The results of
this morphological assay thus show that rabip4 is a periph-
eral membrane protein whose membrane association is de-
pendent on a FYVE domain and perturbed by a PI3-kinase
inhibitor. We attempted to confirm the effect of wortmannin
in biochemical assays; however, whatever subcellular frac-
tionation procedure and buffer we used, most of rabip4
already distributed in the cytosol in the absence of wortman-
nin (our unpublished data).
rabip4 Is Associated with Early Endosomes
Because EEA1 distribution is restricted to early endosomes
(So¨nnichsen et al., 2000) and because some of the structures
contained only EEA1, whereas others were positive for
rabip4 (Figure 2C), we also compared the localization of
rabip4 to other compartments of the transferrin receptor
(TfR) pathway. For this purpose, Alexa594-Tf was internal-
ized for 30 min in HeLa cells expressing VSV-G–tagged
rabip4. Most if not all of the endosomes that were decorated
with the anti-VSV-G-tag antibody (Figure 3A) contained
Alexa594-Tf, whereas a portion of Alexa594-Tf endosomes
(Figure 3B) did not contain rabip4 as evidenced by the
merged images (Figure 3C). FYVE domain proteins do not
exclusively localize to early endocytic compartments; for
instance, PIKfyve is on late endocytic endosomes (Ikonomov
et al., 2001), whereas Fgd1 and DFCP1 are on the Golgi
complex (Estrada et al., 2001; Ridley et al., 2001). We there-
fore investigated whether rabip4 was present in the trans-
Golgi network, in double label experiments with antibodies
against rabip4 (Figure 3D) and the trans-Golgi network
marker TGN46 (Figure 3E). As shown in the merged image
(Figure 3F), rabip4 and TGN46 did not colocalize. Double
labeling experiments of rabip4 (Figure 3G) and LAMP-1
(Figure 3H), a protein associated with late endosomes/lyso-
somes, showed very little overlap (Figure 3I). Together,
these data indicate that the membranous structures to which
rabip4 binds are EEs.
rabip4 Regulates Transport through Early Endosomes
The extensive colocalization between rabip4 and Tf in EEs
and the absence of rabip4 on the plasma membrane, sug-
gested that it might function in a distal transport step of the
TfR pathway. We therefore examined the effect of rabip4 on
transit of endocytosed Tf through EEs. HeLa cells were
transiently transfected with wild-type rabip4, or the CC13-
FYVE rabip4 mutant lacking the N-terminal aa 1–290, in-
cluding the RUN domain (Figure 1B). Alexa594-Tf was in-
ternalized for 30 min at 16°C to accumulate the probe in EEs
(Lim et al., 2001). Cells were then washed and chased at 37°C
in the presence of Desferal to prevent reinternalization of
recycled tracer. As shown in Figure 4E, CC13-FYVE rabip4
caused extensive swelling of EEs and inhibited entry of
Alexa594-Tf in EEs at 16°C compared with cells expressing
wild-type rabip4 (Figure 4A) and the nontransfected cells
in Figure 4E. During the first 10 min of chase, the tracer
reached the swollen EEs in cells transfected with CC13-
FYVE rabip4, but exit of Alexa594-Tf from these structures
was completely blocked during a 40-min chase (Figure 4F–
H). In contrast, in nontransfected cells or wild-type rabip4
transfectants, most if not all Alexa594-Tf was chased out of
the cells after 40 min. Thus, CC13-FYVE rabip4 seemed to
act as an inhibitory mutant delaying entry into and inhibit-
ing recycling from EEs.
We next investigated whether the ectopically expressed
rabip4 FYVE domain affected endosome morphology and
Tf recycling. To this aim, we transfected HeLa cells with the
isolated FYVE domain (HA-rabip4-FYVE) and assessed Tf
recycling from endosomes. Nontransfected cells, and cells
expressing the FYVE domain of the endosomal protein
FENS1 (eGFP-FENS1-FYVE) served as controls. In contrast
to FENS1-FYVE that was associated with early endosomes
(Figure 5), rabip4-FYVE localized to the cytoplasm and
plasma membrane as was reported previously (Ridley et al.,
2001; Yang et al., 2002). Neither construct altered the size of
early endosomes or the kinetics of Tf recycling compared
with nontransfected control cells (Figure 5). Using the same
pulse-chase protocol as in Figure 4, we found that within 20
min of chase at 37°C, the entire pool of internalized tracer
was cleared from the three cell lines. Thus, whereas some
isolated FYVE domains contain sufficient information to be
targeted to early endosomes as in case of EEA1 (Stenmark et
al., 1996) and FENS-1 (Ridley et al., 2001), others, for in-
stance, those of Hrs (Raiborg et al., 2001) and rabip4 require
additional sequence determinants. A common feature of the
mentioned FYVE domains is that their overexpression does
not affect the size of early endosomes, nor membrane recy-
cling.
rabip4 Directly Interacts with the GTP-bound Forms of
rab4 and rab5
The phenotypic effects of the CC13-FYVE mutant on TfR
kinetics suggested a cooperative role of rabip4 and the
monomeric GTPases rab5, rab4, and rab11. rab5 is known to
control vesicular transport to EEs (Bucci et al., 1992), whereas
rab4 and rab11 regulate recycling from this compartment
(van der Sluijs et al., 1992b; Ullrich et al., 1996). We therefore
investigated whether rabip4 directly interacted with these
rab proteins by using a GST pull-down assay (Nielsen et al.,
2000). Bacterially expressed GSTrab4, GSTrab5, and
GSTrab11 were bound to GSH beads. The proteins were
then charged with either GTPS or GDP and incubated with
35S-labeled VSV-G–tagged rabip4, produced in an in vitro
transcription-translation reaction. As shown in Figure 6A,
rabip4 directly and preferentially bound to the active form
(20 times the GDP form) of rab4 and rab5, whereas rab5
seemed to bind 2–3 times less rabip4 than rab4. The inter-
action was specific for rab4 and rab5 because rabip4 did not
bind to rab11. To further determine the specificity of the
interaction, we tested a number of rab proteins that localize
to endocytic compartments (rab7, rab15, rab17, and rab22b)
the Golgi complex (rab21) or other organelles (rab27). None
of these, however, bound to rabip4 (Figure 6B). Given that
rab4 and rab5 bound to rabip4, we next investigated
whether their binding sites map to the same or distinct
domains on rabip4. To this aim, we generated a series of
VSV-G–tagged rabip4 deletion mutants (Figure 6C) and
tested their ability to bind to guanine nucleotide-loaded
GSTrab5 or GSTrab4 in the GST pull-down assay. As shown
in Figure 6C, deletion of CC3 abolished binding to both rab4
and rab5. Truncations that retained the ability to bind rab5
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or rab4 did so in a GTP-dependent manner and none bound
to GDP-charged rab4 and rab5 (our unpublished data).
rab4 and rab5 Bind Simultaneously to rabip4
These results showed that amino acids comprising CC3 are
required for binding to rab4 and rab5. We then determined
whether rab4 and rab5 bound simultaneously or competi-
tively to rabip4. To this aim, we immobilized GSTrab5 on
GSH beads, charged it with GTPS, and added rabip4 (from
which the GST moiety had been removed by thrombin) for
2 h at 4°C. The beads were then washed and further incu-
bated at 4°C with rab4-GTPS (isolated from GSTrab4-
GTPS that had been incubated for 2 h with thrombin). After
2 h, beads were washed, and bound proteins were eluted
with EDTA and high salt. This buffer dissociates rab effector
complexes because EDTA chelates away Mg2 ions that are
required for binding of guanine nucleotide (Christoforidis et
al., 1999). As shown in Figure 7A, rab4 (and rabip4) were
bound on beads that contained GSTrab5, but not on control
beads that contained GST. If GSTrab4GTPS was treated for
12 h with thrombin and then used in the binding assay, it
did not bind to the GSTrab5–rabip4 complex. The extended
incubation with thrombin inactivated rab4 (our unpublished
data), and prevented binding of rab4 to rabip4, suggesting
that formation of a ternary complex was specific and re-
quired the active forms of the two rab proteins. To confirm
these results, we performed the assay in a complementary
format in which GSTrabip4 was immobilized on beads that
were subsequently incubated with a saturating amount of
rab5GTPS and up to 10-fold more rab4GTPS. The total
amount of rab proteins in the assay was between 2 and 10
times more than rabip4. At the end of the incubation, we
analyzed the rab proteins bound to the beads by Western
blotting. As shown in Figure 7B, a 10-fold molar excess of
rab4 did not compete off rab5. These results are consistent
with the data in Figure 7A, thus rab4 and rab5 can bind
independently to rabip4.
rabip4 Colocalizes with rab4 and rab5
If rabip4 binds to rab4 and rab5 in vivo, it should colocalize
at least in part with rab4 and rab5. To investigate this, we
cotransfected cells with VSV-G-rabip4 and rab4 or GFP-
rab5 and analyzed their distributions by confocal fluores-
cence microscopy. As shown in Figure 8, we found a nearly
complete colocalization of rabip4 (Figure 8A) and rab4 (Fig-
ure 8B) on EEs that were enlarged with respect to those seen
in Figure 3. rabip4 (Figure 8D) also colocalized with GFP-
rab5 (Figure 8E) as shown in the merged image in Figure 8F.
rab5, in contrast to rab4, however, less extensively colocal-
ized with rabip4, as might be expected from the partial
colocalization of EEA1 and rabip4 (Figure 3) and the re-
ported codistribution of rab5 and EEA1 (So¨nnichsen et al.,
2000). This suggested that rabip4 might bind both rab5 and
rab4 in vivo, which is supported by the ability of rabip4 and
the two GTPases to cause morphological alterations to EEs,
that are similar to those seen after overexpression of rab4
and rab5 and effectors (Vitale et al., 1998; Nagelkerken et al.,
2000; de Renzis et al., 2002). Thus, rabip4 not only colocal-
ized with rab4 and rab5 but also directly interacted with the
active forms of both proteins.
rabip4 Is Associated with a Large Cytosolic Protein
Complex
Recent evidence shows that rab proteins act through the
local assembly of highly specific effector complexes that
contain a myriad of proteins, of which some have been
identified so far. For instance, at least 26 cytosolic proteins
could be isolated on a rab5GTP affinity column, including
rabenosyn-5, EEA1, and rabaptin5 (Christoforidis et al.,
1999). Having found that rabip4 directly binds to rab4 and
rab5, we were interested to know whether endogenous
rabip4 was present as a monomer or within a protein com-
plex in the cytoplasm. To this aim, we fractionated a HeLa
S100 extract by gel filtration on a Superdex 200 HR column.
The majority of rabip4 eluted in fractions corresponding to
a molecular mass 670 kDa (Figure 9). On overexposure of
the Western blot, we detected trace amounts of rabip4 in the
fractions corresponding to its monomeric state (our unpub-
lished data). The rabip4 complex (or complexes) are devoid
of nucleic acids because we did not find RNA or DNA in
immunoprecipitations of [32P]orthophosphate-labeled cells
by using SN569 antibody against-rabip4 (our unpublished
Figure 7. rab4 and rab5 bind simultaneously to rabip4. (A)
GSTrab5 (loaded with GTPS) and GST were immobilized on GSH
beads and incubated with rabip4 (CC13-FYVE). After washing, a
second incubation was performed with rab4-GTPS at a molar ratio
rab5:rab4 of 5. Bound proteins were eluted, resolved by SDS-PAGE,
and analyzed by Western blotting by using antibodies against
rabip4 (SN570) and rab4 (8091). Then, 0.5% of GSTrab5 and GST
was loaded on a SDS-PAA gel and stained with Coomassie Brilliant
Blue (CBB) to control for input in the assays. rab4 bound to the
GSTrab5 beads in the presence rabip4, but not to GST beads when
these were incubated with rabip4. Extending the thrombin cleavage
time of GSTrab4 from 2 to 12 h inactivates GTPS-loaded rab4 and
reduced rab4-binding to background level. (B) GSTrabip4(CC13-
FYVE) and GST were immobilized on GSH beads and first incu-
bated with rab5-GTPS. After washing, increasing amounts of rab4-
GTPS (x stands for 50 g) were added and beads were further
incubated. Bound proteins were eluted, resolved by SDS-PAGE and
analyzed by Western blotting with antibodies against rab4 (8091)
and rab5 (4F11). CBB staining shows that similar amounts of GSTra-
bip4 (CC13-FYVE) and GST have been used in each reaction (1% of
the input). Note that addition of a 10-fold molar excess of rab4 does
not compete out bound rab5.
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data). We also analyzed the column fractions for the pres-
ence of EEA1, the majority of which eluted in fractions 3–7,
showing no overlap with rabip4. rabaptin5, an effector of
rab4 and rab5, eluted in fractions between the rabip4 and
EEA1 peaks, whereas rab5 and rab4 eluted from the column
after the 44-kDa marker. These data demonstrate that the
majority of cytosolic rabip4 is associated with a relatively
large protein complex that is distinct from complexes con-
taining other rab5 effectors.
DISCUSSION
We here describe the identification of rabip4, a novel 80-
kDa protein colocalizing with endocytosed transferrin, rab4,
and albeit to a lesser extent with EEA1, and rab5 on EEs. We
isolated rabip4 from HeLa cells with the high-affinity SW5
mAb against La. The molecular basis for the interaction
between SW5 and rabip4 likely involves charged amino
acid residues that adopt a -helical coil in the SW5 epitope
present in both La and rabip4 (Fouraux et al., 2002a). The
primary structure of rabip4 displays some homology to
EEA1, particularly in the FYVE-finger domain. rabip4, how-
ever, is distinct from EEA1. First, rabip4 contains an N-
terminal RUN domain and has a significantly lower coiled-
coil content than EEA1. Second, both rab4 and rab5 bind to
rabip4, a property that is not shared by EEA1. These fea-
tures suggest that rabip4 is an effector of rab5 and rab4 and
relies on the presence of a FYVE-domain to localize to EEs.
During the preparation of this manuscript, Yang et al.
reported the identification of RUFY1, a human protein in-
teracting with Etk that serves as a substrate of this tyrosine
kinase (Yang et al., 2002), whereas Cormont et al. identified
rabip4, a murine rab4 effector (Cormont et al., 2001; Mari et
al., 2001). RUFY1 and rabip4 are nearly identical (95%) and
possibly represent orthologs, although their tissue distribu-
tion does not seem to be identical. Sequence comparison of
rabip4 with RUFY1 and rabip4 revealed extensive homol-
ogy except for the N-terminal 108 aa of rabip4, which are
not present in RUFY1 and rabip4. BLAST searches with this
region of rabip4 revealed that the mouse genome encodes a
long variant of rabip4 with an N-terminal extension of 112
aa (accession no. BAC32815) that is highly homologous to
the N terminus of rabip4. There are two more variants in
mouse with the N terminal extension (BAC34548 and
BAC32811). However, these contain C-terminal truncations,
lack the FYVE domain and encode shorter proteins than
rabip4. Because there is only one gene encoding these
polypeptides, this shows that at least two isoforms are ex-
pressed, a short one, RUFY1/rabip4, and a long version
represented by rabip4/BAC 32815. The results from a re-
cent EST database search strongly suggest that the long and
short isoforms result from transcription initiation at alterna-
tive promoters in the rabip4/RUFY1 gene (our unpublished
data). Because the N-terminal 108 aa of rabip4 does not
constitute known protein motifs, it is not immediately pre-
dictable in what respect this region might contribute to the
functional properties of the protein. We do note, however,
that this part of rabip4 lies directly adjacent to the RUN
domain, a conserved element found in many proteins that
are known to functionally associate with GTPases of the rab
and rap subfamilies (Callebaut et al., 2001). Importantly,
rabip4 binds to both rab4 and rab5 and is involved in
transport steps that are regulated by rab5 and rab4, whereas
rabip4 reportedly does not interact with rab5 (Cormont et al.,
2001).
Analysis of the rabip4 N-RUN-CC13 deletion mutant
showed that the FYVE-finger domain plays an essential role
in the binding of rabip4 to early endosomal membranes.
Low concentrations of wortmannin selectively inhibit PI3-
kinase and resulted in the redistribution of rabip4 from EEs
to the cytoplasm, suggesting that PI(3)P is required for the
early endosomal association of rabip4. Currently, it is not
known whether other proteins are involved in the associa-
tion of rabip4 with EEs, as is the case for rabenosyn-5
(Nielsen et al., 2000) and EEA1 (Simonsen et al., 1998). En-
dosome association of these rab5 effectors also involves
binding to rab5-GTP, which in EEA1 interacts with a region
comprising the FYVE domain and flanking amino acids
(Lawe et al., 2000), and dimerization (Dumas et al., 2001).
Aligning this region of EEA1 with rabip4 revealed a homol-
ogous element immediately upstream (aa 562–647) of the
FYVE-domain in rabip4 with 31% identity and 42% simi-
larity. Interestingly, this part of rabip4 is 89% identical to
the rab4 binding domain of rabip4 (Cormont et al., 2001) and
Figure 8. rab4 and rab5 colocalize with
rabip4. HeLa cells expressing VSV-G-
rabip4 and rab4 (A-C), or VSV-G-rabip4
and EGFP-rab5 (D–F) were labeled with a
mAb against the VSV-G tag and counter-
stained with either Alexa488-goat anti-
mouse IgG (A) or Alexa594-goat anti-mouse
(D). rab4 was labeled with a rabbit antibody
and stained with Cy3-goat anti-rabbit IgG
(B), whereas rab5 was detected by EGFP
fluorescence (E). Merged images are shown
in C and F, and colocalization is indicated
by arrows. Bar, 10 m.
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contains the rab4 and rab5 binding domain in CC3 (Figure
6C). Because N-RUN-CC13 rabip4 (Figure 2E) is localized in
the cytoplasm, it is clear that binding of rabip4 to rab4
and/or rab5 is not sufficient for the association with EEs.
Because PI(3)P is not exclusively localized to EEs but also
occurs in late endocytic compartments as well as in the
nucleus (Gillooly et al., 2000), we inferred that rab4 and/or
rab5 binding and the FYVE domain are minimally required
for endosomal recruitment of rabip4.
The in vitro binding studies showed that rab5 and rab4 in
their GTP-bound form directly interact with rabip4. The
interaction with the two GTPases was specific because none
of the other rab proteins that we tested bound to rabip4,
including rab11, which is also functionally associated with
compartments of the TfR pathway (Ullrich et al., 1996; Wil-
cke et al., 2000). These interactions suggest that rabip4 may
coordinate rab4 and rab5 function in regulating transport
through EEs. This idea is supported by several of our find-
ings. First, rabip4 is associated with EEs that contain rab4
and rab5. Second, the CC13-FYVE rabip4 mutant acts as an
inhibitor of Tf transport to or entry into EEs, a step that is
typically controlled by rab5. Third, CC13-FYVE rabip4 gen-
erated enlarged EEs, a phenotype also arising from the
expression of rab5 and its effector proteins. Fourth, CC13-
FYVE rabip4 inhibits the exit or recycling of Tf from EEs, an
event that is regulated by rab4.
What would be the purpose of a protein that binds two
endosomal GTPases? Previous studies have shown that
rab5, rab4, and rab11 containing endosomes are reached in
this order by endocytosed Tf (Trischler et al., 1999). Triple
label fluorescence microscopy of Zerial’s group confirmed
these biochemical data (So¨nnichsen et al., 2000) and also
showed that pairs of these sequentially acting rab proteins
had distinct and partially overlapping distributions. It is
thought that rab proteins may form domains in the lateral
plane of a membrane by recruiting effectors and other inter-
acting molecules to control a specific membrane transport
event (McBride et al., 1999). Extrapolation of this hypothesis
suggests that the morphological and biochemical heteroge-
neity of early endocytic organelles can be materialized in
terms of domains that are formed by rab5, rab4, and rab11
(So¨nnichsen et al., 2000). The spatial coordination of rab5-
dependent entry and rab4-mediated exit of Tf can then
simply be brought about by connecting the rab5 and rab4
Figure 9. Cytosolic rabip4 is associated with a large protein complex. A HeLa S100 extract was fractionated by Superdex 200 HR 10/30 gel
filtration chromatography as described in MATERIALS AND METHODS. The position of marker proteins is indicated above the elution
profile. Column fractions were analyzed by Western blotting with antibodies against rabip4, EEA1, rab5, rab4, and rabaptin5. The positions
of the various proteins are indicated with arrows.
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domains via bivalent effector molecules that have the ability
to bind both rab5 and rab4. Coupling of the domains might
be strengthened by the cooperative activities of bivalent
effectors such as rabenosyn-5, rabaptins, or rabip4. In this
respect, rabip4 is more similar to Rab coupling protein,
which binds to rab4 and rab11 in a short C-terminal domain
(Lindsay et al., 2002), than to the rabaptins in which the
binding sites are separated by a long interspacing sequence
(Vitale et al., 1998).
An alternative model for rab5- and rab4-dependent bind-
ing in rabip4 function that is consistent with our data is
suggested by findings of others on RUFY1. This rabip4
homolog binds to the tyrosine kinase Etk in a phosphoryla-
tion-dependent manner (Yang et al., 2002). Etk-mediated
phosphorylation occurs on two tyrosine residues that are
completely conserved between RUFY1, rabip4, rabip4, and
BAC32815. Interestingly, the RUFY1–Etk complex regulates
epidermal growth factor-induced internalization of the epi-
dermal growth factor receptor (Yang et al., 2002), which is a
rab5-dependent event (Tall et al., 2001). Possibly members of
the RUFY1, rabip4, rabip4, and BAC32815 family might link
cell surface signaling to rab4-dependent receptor recycling.
Cytosolic rabip4 is associated with a large (670-kDa)
protein complex that does not contain EEA1 and rabaptin5,
suggesting that it is distinct from the previously identified
rab5 effector complex consisting of EEA1-rabaptin5-rabex5-
syntaxin13 (McBride et al., 1999). Although we have not yet
identified other components of the complex, the modular
structure of rabip4 affords association with multiple pro-
teins via its leucine zippers and/or coiled-coil domains,
which are established protein–protein interaction domains
(Alber, 1992; Lupas, 1996). Cytosolic rab4 and rab5 did not
cofractionate with the complex, possibly because they are
present in the cytosol in the GDP-bound form (Stenmark et
al., 1994; Gerez et al., 2000) that does not bind to effector
proteins. Alternatively, the rabip4 association with the GT-
Pases might be transient and determined by cycles of GTP-
hydrolysis and GDP exchange reactions that preclude their
cofractionation. Similarly, the multimeric rab5 endosomal
docking/fusion complex (McBride et al., 1999) did not con-
tain rab5. Possibly, the cytosolic rabip4 complex might
serve as a precomplex that is activated upon binding to
rab4/rab5 on EEs.
ACKNOWLEDGMENTS
We thank our colleagues for the generous supply of reagents, and members
of our laboratories for insightful comments. We also thank Dr. L. Meheus
(Innogenetics N.V.) for mass spectrometry and Erik Vossenaar for help in the
preparation of figures. This work was supported by grants from the Nether-
lands Organization for Scientific Research (NWO-CW to G.P., and NWO-
ALW to P.v.d.S.).
REFERENCES
Alber, T. (1992). Structure of the leucine zipper. Curr. Opin. Genet. Dev. 2,
205–210.
Bache, K.G., Brech, A., Mehlum, A., and Stenmark, H. (2003). Hrs regulates
multivesicular body formation via ESCRT recruitment to endosomes. J. Cell
Biol. 162, 435–442.
Bottger, G., Nagelkerken, B., and van der Sluijs, P. (1996). Rab4 and rab7
define distinct endocytic compartments. J. Biol. Chem. 271, 29191–29197.
Bucci, C., Parton, R., Mather, I., Stunnenberg, H., Simons, K., and Zerial, M.
(1992). The small GTPase rab5 functions as a regulatory factor in the early
endocytic pathway. Cell 70, 715–728.
Burd, C.G., and Emr, S.D. (1998). Phosphatidylinositol(3)-phosphate signaling
mediated by specific binding to RING FYVE domains. Mol. Cell 2, 157–162.
Callebaut, I., de Gunzberg, J., Goud, B., and Mornon, J.P. (2001). RUN do-
mains: a new family of domains involved in ras-like GTPase signaling. Trends
Biochem. Sci. 26, 79–83.
Christoforidis, S., McBride, H., Burgoyne, R.D., and Zerial, M. (1999). The rab5
effector EEA1 is a core component of endosome docking. Nature 397, 621–625.
Cormont, M., Mari, M., Galmiche, A., Hofman, P., and Le Marchand-Brustel,
Y. (2001). A FYVE finger-containing protein, rabip4, is a rab4 effector protein
involved in early endosomal traffic. Proc. Natl. Acad. Sci. USA 98, 1637–1642.
de Renzis, S., So¨nnichsen, B., and Zerial, M. (2002). Divalent rab effectors
regulate the sub-compartmental organization and sorting function of early
endosomes. Nat. Cell Biol. 4, 124–133.
Deneka, M., Neeft, M., Popa, I., van Oort, M., Sprong, H., Oorschot, V.,
Klumperman, J., Schu, P., and van der Sluijs, P. (2003). rabaptin-5/rabap-
tin-4 serves as a linker between rab4 and 1-adaptin in membrane recycling
from endosomes. EMBO J. 22, 2645–2657.
Dumas, J.J., Merithew, E., Sudharshan, E., Rajamani, D., Hayes, S., Lawe, D.,
Corvera, S., and Lambright, D.G. (2001). Multivalent endosome targeting by
homodimeric EEA1. Mol. Cell 8, 947–958.
Estrada, L., Caron, E., and Gorski, J.L. (2001). Fgd1, the cdc42 guanine nucle-
otide exchange factor responsible for faciogeneital dysplasia, is localized to
the subcortical actin cytoskeleton and Golgi membrane. Hum. Mol. Gen. 10,
485–495.
Fernandez-Borja, M., Wubbolts, R., Calafat, J., Janssen, H., Divecha, N., Dus-
seljee, S., and Neefjes, J. (1999). Multivesicular body morphogenesis requires
phosphatidyl-inositol 3-kinase activity. Curr. Biol. 9, 55–58.
Fouraux, M., van der Heijden, A., van Venrooij, W.J., and Pruijn, G.J.M.
(2002a). Cross-reactivity of the anti-La mAb SW5 with early endosome anti-
gen 2. Immunology 106, 336–342.
Fouraux, M.A., Bouvet, P., Verkaart, S., van Venrooij, W.J., and Pruijn, G.J.M.
(2002b). Nucleolin associates with a subset of the human Ro ribonucleopro-
tein complexes. J. Mol. Biol. 320, 475–488.
Gaullier, J.M., Simonsen, A., D’Arrigo, A., Bremnes, B., Stenmark, H., and
Aasland, R. (1998). FYVE fingers bind PtdIns(3)P. Nature 394, 432–433.
Gerez, L., Mohrmann, K., van Raak, M., Jongeneelen, M., Zhou, X.Z., Lu, K.P.,
and van der Sluijs, P. (2000). Accumulation of rab4 GTP in the cytoplasm and
association with the peptidyl-prolyl isomerase Pin1 during mitosis. Mol. Biol.
Cell 11, 2201–2211.
Gillooly, D.J., Morrow, I.C., Lindsay, M., Gould, R., Bryant, N.J., Gaullier,
J.M., Parton, R.G., and Stenmark, H. (2000). Localization of phosphatidylino-
sitol 3-phosphate in yeast and mammalian cels. EMBO J. 19, 4577–4588.
Harter, C., and Mellman, I. (1992). Transport of the lysosomal membrane
glycoprotein lgp120 (lgp-A) to lysosomes does not require appearance on the
plasma membrane. J. Cell Biol. 117, 311–325.
Hayes, S., Chawla, A., and Corvera, S. (2002). TGFbeta receptor internaliza-
tion into EEA1-enriched early endosomes: role in signaling to Smad2. J. Cell
Biol. 158, 1239–1249.
Ikonomov, O.C., Sbrissa, D., and Shisheva, A. (2001). Mammalian cell mor-
phology and endocytic membrane homeostasis require enzymatically active
phosphoinositide 5-kinase PIKfyve. J. Biol. Chem. 276, 26141–26147.
Lawe, D.C., Chawla, A., Merithew, E., Dumas, J., Carrington, W., Fogarty, K.,
Lifshitz, L., Tuft, R., Lambright, D., and Corvera, S. (2002). Sequential roles for
phosphatidylinositol 3-phosphate and rab5 in tethering and fusion of early
endosomes via their interaction with EEA1. J. Biol. Chem. 277, 8611–8617.
Lawe, D.C., Patki, V., Harrison, R.H., Lambright, D., and Corvera, S. (2000).
The FYVE domain of early endosome associated antigen 1 is required for both
phosphatidylinositol 3-phosphate and rab5 binding. J. Biol. Chem. 275, 3699–
3705.
Lewis, M.J., Nichols, B.J., Baschong, C.P., Riezman, H., and Pelham, H.R.B.
(2000). Specific retrieval of the exocytic SNARE Snc1p from early yeast endo-
somes. Mol. Biol. Cell 11, 23–38.
Lim, S.N., Bonzelius, F., Low, S.H., Wille, H., Weimbs, T., and Herman, G.A.
(2001). Identification of discrete classes of endosome-derived small vesicles as
major cellular pool for recycling membrane proteins. Mol. Biol. Cell 12,
981–995.
Lindsay, A.J., Hendrick, A.G., Cantalupo, G., Matuglia, F.S., Goud, B., Bucci,
C., and McCaffrey, M.W. (2002). Rab coupling protein (RCP), a novel rab4 and
rab11 effector protein. J. Biol. Chem. 277, 12190–12199.
Lupas, A. (1996). Coiled coils: new structures and new functions. Trends
Biochem. Sci. 21, 375–382.
Maraia, R.J., and Intine, R.V.A. (2001). Recognition of nascent RNA by the
human La antigen: conserved and divergent features of structure and func-
tion. Mol. Cell Biol. 21, 367–379.
rabip4, a Novel Early Endosomal Protein
Vol. 15, February 2004 623
Mari, M., Maci, E., Le Marchand-Brustel, Y., and Cormont, M. (2001). Role of
the FYVE finger and the RUN domain for the subcellular localization of
rabip4. J. Biol. Chem. 276, 42501–42508.
McBride, H.M., Rybin, V., Murphy, C., Giner, A., Teasdale, R., and Zerial, M.
(1999). Oligomeric complexes link rab5 effectors with NSF and drive mem-
brane fusion via interactions between EEA1 and syntaxin 13. Cell 98, 377–386.
Mellman, I. (1996). Endocytosis and molecular sorting. Annu. Rev. Cell Dev.
Biol. 12, 575–626.
Miura, S., et al. (2000). Hgs (Hrs), a FYVE domain protein, is involved in Smad
signaling through cooperation with SARA. Mol. Cell Biol. 20, 9346–9355.
Mukherjee, S., Ghosh, R.N., and Maxfield, F.R. (1997). Endocytosis Physiol.
Rev. 77, 759–803.
Nagelkerken, B., van Anken, E., van Raak, M., Gerez, L., Mohrmann, K., van
Uden, N., Holthuizen, J., Pelkmans, L., and van der Sluijs, P. (2000). Rabap-
tin4, a novel effector of rab4a, is recruited to perinuclear recycling vesicles.
Biochem. J. 346, 593–601.
Nielsen, E., Christoforidis, S., Utenwiler-Joseph, S., Miaczynska, M., Dewitte,
F., Wilm, M., Hoflack, B., and Zerial, M. (2000). Rabenosyn-5, a novel rab5
effector, is complexed with hVPS45 and recruited to endosomes through a
FYVE finger domain. J. Cell Biol. 151, 601–612.
Panopoulou, E., Gillooly, D.J., Wrana, J.L., Zerial, M., Stenmark, H., Murphy,
C., and Fotsis, T. (2002). Early endosomal regulation of Smad-dependent
signaling in endothelial cells. J. Biol. Chem. 277, 18046–18052.
Patki, V., Lawe, D.C., Corvera, S., Virbasius, J.V., and Chawla, A. (1998). A
functional PtdIns(3P)-binding motif. Nature 394, 433–434.
Pruijn, G.J., Thijssen, J.P., Smith, P.R., Williams, D.G., and van Venrooij, W.J.
(1995). Anti-La monoclonal antibodies recognizing epitopes with the RNA-
binding domain of the La protein show differential capacities to immunopre-
cipitate RNA-associated La protein. Eur. J. Biochem. 232, 611–619.
Pruijn, G.J.M. (1994). The La (SS-B) antigen. In: Manual of Biological Markers
of Disease, ed. W.J. van Venrooij and R.N. Maini, Dordrecht: Kluwer Aca-
demic Publishers, B4.2/1–B4.2/14.
Raiborg, C., Bache, K.G., Gillooly, D.J., Madshus, I.H., Stang, E., and Sten-
mark, H. (2002). Hrs sorts ubiquitinated proteins into clathrin-coated mi-
crodomains of early endosomes. Nat. Cell Biol. 4, 394–398.
Raiborg, C., Bache, K., Mehlum, A., Stang, E., and Stenmark, H. (2001). Hrs
recruits clathrin to early endosomes. EMBO J. 20, 5008–5021.
Raiborg, C., Bremnes, B., Mehlum, A., Gillooly, D., D’Arrigo, A., Stang, E.,
and Stenmark, H. (2001). FYVE and coiled coil domains determine the specific
localization of Hrs to early endosomes. J. Cell Sci. 114, 2255–2263.
Raymackers, J., Daniels, A., de Brabandere, V., Missiaen, C., Dauwe, M.,
Verhaert, P., van Mechelen, E., and Meheus, L. (2000). Identification of two-
dimensionally separated human cerebrospinal fluid proteins by N-terminal
sequencing, matrix assisted laser desorption/ionization-mass spectrometry,
nanoliquid chromatography electrospray ionization-time of flight-mass spec-
trometry, and tandem mass spectrometry. Electrophoresis 21, 2266–2283.
Ridley, S.H., et al. (2001). FENS-1 and DFCP1 are FYVE domain-containing
proteins with distinct functions in the endosomal and Golgi compartments.
J. Cell Sci. 114, 3991–4000.
Roberts, M., Barry, S., Woods, A., van der Sluijs, P., and Norman, J. (2001).
Rab4-dependent recycling of v3 integrin from early endosomes is neces-
sary for cell adhesion and spreading. Curr. Biol. 11, 1392–1402.
Schultz, J., Milpetz, F., Bork, P., and Ponting, C.P. (1998). SMART, a simple
modular architecture research tool: identification of signaling domains. Proc.
Natl. Acad. Sci. USA 95, 5857–5864.
Schwabe, J.W., and Klug, A. (1994). Zinc mining for protein domains. Nat.
Struct. Biol. 1, 345–349.
Seet, L.F., and Hong, W. (2001). Endofin, an endosomal FYVE domain protein.
J. Biol. Chem. 276, 42445–42454.
Simonsen, A., Lippe, R., Christoforidis, S., Gaullier, J.M., Brech, A., Callaghan,
J., Toh, B.H., Murphy, C., Zerial, M., and Stenmark, H. (1998). EEA1 links
PI(3)K function to rab5 regulation of endosome fusion. Nature 394, 494–498.
Soldati, T., and Perriard, J.C. (1991). Intracompartmental sorting of essential
myosin light chains: molecular dissection and in vivo monitoring by epitope
tagging. Cell 66, 277–289.
So¨nnichsen, B., de Renzis, S., Nielsen, E., Rietdorf, J., and Zerial, M. (2000).
Distinct membrane domains on endosomes in the recycling pathway visual-
ized by multicolor imaging of rab4, rab5, and rab11. J. Cell Biol. 149, 901–913.
Sprong, H., Degroote, S., Claessens, T., van Drunen, J., Oorschot, V., West-
erink, B.H.C., Hirabayashi, Y., Klumperman, J., van der Sluijs, P., and van
Meer, G. (2001). Glycosphingolipids are required for sorting melanosomal
proteins in the Golgi complex. J. Cell Biol. 155, 369–379.
Stenmark, H., and Aasland, R. (1999). FYVE finger proteins-effectors of an
inositol lipid. J. Cell Sci. 112, 4175–4183.
Stenmark, H., Aasland, R., Toh, B.H., and D’Arrigo, A. (1996). Endosomal
localization of the autoantigen EEA1 is mediated by a Zinc-binding FYVE
finger. J. Biol. Chem. 271, 24048–24054.
Stenmark, H., Parton, R., Steele-Mortimer, O., Lutcke, A., Gruenberg, J., and
Zerial, M. (1994). Inhibition of rab5 GTPase activity stimulates membrane
fusion in endocytosis. EMBO J. 13, 1287–1296.
Stenmark, H., Vitale, G., Ullrich, O., and Zerial, M. (1995). Rabaptin-5 is a
direct effector of the small GTPase rab5 in endocytic membrane fusion. Cell
83, 423–432.
Tall, G.G., Barbieri, M.A., Stahl, P.D., and Horazdovsky, B.F. (2001). Ras-
activated endocytosis is mediated by the rab5 guanine nucleotide exchange
activity of RIN1. Dev. Cell 1, 73–82.
Trischler, M., Stoorvogel, W., and Ullrich, O. (1999). Biochemical analysis of
distinct rab5- and rab11 positive endosomes along the transferrin pathway.
J. Cell Sci. 112, 4773–4783.
Tsukazaki, T., Chiang, T.A., Davison, A.F., Attisano, L., and Wrana, J.L.
(1998). SARA, a FYVE domain protein that recruits Smad2 to the TGF-
receptor. Cell 95, 779–791.
Ullrich, O., Reinsch, O., Urbe, S., Zerial, M., and Parton, R. (1996). Rab11
regulates recycling through the pericentriolar recycling endosome. J. Cell Biol.
135, 913–924.
Urbe, S., Mills, I., Stenmark, H., Kitamura, N., and Clague, M.J. (2000).
Endosomal localization and receptor dynamics determine tyrosine phosphor-
ylation of hepatocyte growth factor regulated tyrosine kinase substrate. Mol.
Cell Biol. 20, 7685–7692.
van Dam, E., and Stoorvogel, W. (2002). Dynamin-dependent transferrin
recycling by endosome-derived clathrin-coated vesicles. Mol. Biol. Cell 13,
169–182.
van der Sluijs, P., Hull, M., Huber, L.A., Male, P., Goud, B., and Mellman, I.
(1992a). Reversible phosphorylation-dephosphorylation determines the local-
ization of rab4 during the cell cycle. EMBO J. 11, 4379–4389.
van der Sluijs, P., Hull, M., Webster, P., Goud, B., and Mellman, I. (1992b). The
small GTP binding protein rab4 controls an early sorting event on the endo-
cytic pathway. Cell 70, 729–740.
Vitale, G., Rybin, V., Christoforidis, S., Thornqvist, P.O., McCaffrey, M.,
Stenmark, H., and Zerial, M. (1998). Distinct rab-binding domains mediate the
interaction of rabaptin-5 with GTP-bound rab4 and rab5. EMBO J. 17, 1941–
1951.
Wilcke, M., Johannes, L., Galli, T., Mayou, V., Goud, B., and Salamero, J.
(2000). Rab11 regulates the compartmentalization of early endosomes re-
quired for efficient transport from early endosomes to the trans Golgi net-
work. J. Cell Biol. 151, 1207–1220.
Yang, J., Kim, O., and Qiu, Y. (2002). Interaction between tyrosine kinase Etk
and a RUN domain and FYVE domain containing protein RUFY1. J. Biol.
Chem. 277, 30219–30226.
M.A. Fouraux et al.
Molecular Biology of the Cell624
